A network-based classification model for deriving novel drug-disease associations and assessing their molecular actions.
The growing number and variety of genetic network datasets increases the feasibility of understanding how drugs and diseases are associated at the molecular level. Properly selected features of the network representations of existing drug-disease associations can be used to infer novel indications o...
Guardado en:
Autores principales: | Min Oh, Jaegyoon Ahn, Youngmi Yoon |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/14548046d03b4ece917b742310a02804 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Classification of drugs based on mechanism of action using machine learning techniques
por: H. L. Gururaj, et al.
Publicado: (2021) -
Current data on the effectiveness of gliclazide and molecular mechanisms of action of the drug
por: Nina A. Petunina, et al.
Publicado: (2020) -
Molecular classification of prostate adenocarcinoma by the integrated somatic mutation profiles and molecular network
por: Lei Yang, et al.
Publicado: (2017) -
Drug repurposing for Chagas disease: In vitro assessment of nimesulide against Trypanosoma cruzi and insights on its mechanisms of action.
por: Joana D'Arc S Trindade, et al.
Publicado: (2021) -
Drug repurposing for Chagas disease: In vitro assessment of nimesulide against Trypanosoma cruzi and insights on its mechanisms of action
por: Joana D’Arc S. Trindade, et al.
Publicado: (2021)